IRD vs LI · rev $11.0M vs P/E 24, rev $16.06B
Opus Genetics, Inc. (IRD) versus Li Auto Inc (LI) — a side-by-side from cached financials, not a winner call.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Li Auto Inc (LI) is a auto manufacturers company listed on US.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
Latest reported LI revenue for 2025-12-31 was $16.06B. Net income was $162.9M. Revenue was down 18.8% from 2024-12-31 to 2025-12-31. LI currently screens at market cap $26.62B and trailing P/E 24.2.
IRD currently screens at market cap $35.7M. LI currently screens at market cap $26.62B and trailing P/E 24.2.
Not investment advice. Open the IRD and LI stock pages for the full models.
Not investment advice.